This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Nektar Therapeutics Inc (NKTR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 39.07M 25.44M 15.31M 17.76M
Receivables 2.23M 5.80M 4.94M 25.10M
Inventories 13.45M 18.27M 12.66M 7.27M
Other Current Assets 5.18M 13.36M 17.94M 5.68M
Total Current Assets 257.88M 314.63M 276.71M 353.98M
Property, Plant & Equipment, Gross 151.12M 144.88M 140.81M 143.77M
Accumulated Depreciation & Depletion 84.15M 72.67M 62.24M 53.99M
Property, Plant & Equipment, Net 66.97M 72.22M 78.58M 89.77M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 33.17M 34.44M 174.77M 972.00K
Total Non-Current Assets 176.64M 183.16M 329.84M 167.25M
Liabilities & Shareholder Equity
Total Assets 434.53M 497.79M 606.55M 521.22M
Accounts Payable 9.12M 2.86M 3.02M 7.19M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 21.12M 12.41M 6.49M 6.39M
Total Current Liabilities 98.22M 78.54M 275.53M 64.11M
Long Term Debt 125.00M 125.00M 0.00 214.96M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 293.16M 235.63M 118.62M 134.49M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 426.21M 372.24M 133.21M 366.46M
Total Liabilities 524.43M 450.77M 408.74M 430.56M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -89.90M 47.02M 197.81M 90.66M
Common Par 11.00K 11.00K 11.00K 9.00K
Additional Paid In Capital 1.64B 1.62B 1.60B 1.35B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.73B -1.57B -1.40B -1.26B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -1.18M -357.00K -1.10M 968.00K
Total Capitalization 35.10M 172.02M 197.81M 305.62M
Total Equity -89.90M 47.02M 197.81M 90.66M
Total Liabilities & Stock Equity 434.53M 497.79M 606.55M 521.22M
Total Common Shares Outstanding 116.49M 115.26M 114.48M 94.52M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 115.73M 114.82M 112.94M 94.08M
Diluted Weighted Shares Outstanding 115.73M 114.82M 112.94M 94.08M
Number of Employees 445 433 423 408
Number of Part-Time Employees 0 0 0 0

NKTR Nektar Therapeutics Inc

Analysts Ratings for NKTR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 7 7
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

Brokerage Partners

NKTR Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs